


The aim of the Fund is to provide a growing income with capital growth.
| Name | % Net Assets |
|---|---|
| Vodafone Group PLC | 4.1% |
| GlaxoSmithKline PLC | 3.2% |
| BT Group PLC | 2.7% |
| Legal & General Group PLC | 2.6% |
| AstraZeneca PLC | 2.5% |
| Unilever PLC | 2.5% |
| Imperial Tobacco Group PLC | 2.4% |
| British American Tobacco PLC | 2.2% |
| RSA Insurance Group PLC | 1.9% |
| BAE Systems PLC | 1.7% |
| Key | % Net Assets |
|---|---|
| 4.1% | |
| 3.2% | |
| 2.7% | |
| 2.6% | |
| 87.4% |
| Date | 09-Apr-2021 |
|---|---|
| Bid | 77.80p |
| Offer | 77.80p |
| Currency | GBP |
| Change | 0.13p |
| % | 0.17% |
| YTD change | 77.80p |
| YTD % | n/a |
| Fund Inception | 26/08/1997 |
|---|---|
| Fund Manager | Chris White |
| TER | 1.81 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £2000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 3.75% |
| Annual Mang't | 0.25% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.07 |
You are here: research